Cel Sci Corporation (CVM)

[fluteman]

I don't want to discuss the other stock anymore, as that is water under the bridge.

But, it has had multiple trials and multiple failures, over an 8-year period or so.

They have tried to resuscitate the drug for new applications (sounds familiar?).

Yes, I expect a bit pull back on CVM, and I will buy again---hopefully it cleans my previous losses from years ago.

https://seekingalpha.com/article/225196-cell-therapeutics-to-challenge-fda-decision

"Moreover, management believes that the study conducted by it was the first and only randomized trial in this patient population, which demonstrated significant improvement in clinically relevant endpoints such as complete response rate, overall response rate and progression free survival. Additionally, the candidate was found to be a safe and effective therapy for the indication.